• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Silicone aluminum adhesive - H
Water resistant silicone aluminum adhesive - W
Silica Gel for Column-layer chromatography
Silica Gel for Variable-Pressure Adsorption
White silicone
Container desiccant

TUL Degu and Liraglutide insulin compound preparation obtained clinical approval.

April 27, 2023

Tag:

TUL Degu and Liraglutide insulin compound preparation obtained clinical approval.

Previous:350 million project construction started, and the development potential of TUL was accelerated

Next:First in China! The weight management medicine of Smeglutide Injection of TUL was approved for clini

You may like
More>>

Diethylenetriaminepentaacetic acid，DTPA

Diethylenetriaminepentaacetic acid，DTPA
BORIC ACID

BORIC ACID
PP storage cabinet ventilated medicine cabinet

PP storage cabinet ventilated medicine cabinet
CYTIDINE 5'-DIPHOSPHOCHOLINE

CYTIDINE 5'-DIPHOSPHOCHOLINE
Alfalfa Extract Powder

Alfalfa Extract Powder
N-phenyl-4-(4-phenylnaphthalen-1-yl)aniline

N-phenyl-4-(4-phenylnaphthalen-1-yl)aniline
1,7-Heptanediol 629-30-1

1,7-Heptanediol 629-30-1
2,3-Difluorobenzonitrile

2,3-Difluorobenzonitrile
Halal Barley Grass/Green Extract Powder/Juice Powder10:1

Halal Barley Grass/Green Extract Powder/Juice Powder10:1
Benzaldehyde

Benzaldehyde

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service